United Therapeutics (UTHR) Tops Q3 EPS by 16c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $511.26 -0.36%
Financial Fact:
Cost of product sales: 23.6M
Today's EPS Names:
XYF, SQZB, RENO, More
Financial Fact:
Cost of product sales: 23.6M
Today's EPS Names:
XYF, SQZB, RENO, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $3.50, $0.16 better than the analyst estimate of $3.34. Revenue for the quarter came in at $408.2 million versus the consensus estimate of $402.35 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
- Morgan Stanley sees quality stocks and AI adopters leading market
- Bernstein SocGen on StandardAero Inc (SARO): ' Solid revenues, but short-term margin issues'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
